Zdeněk Coufal

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2017 · 56 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +8

Uric acid, allopurinol therapy, and mortality in patients with acute heart failure—results of the Acute HEart FAilure Database registry

Filip Málek, Petr Ošťádal, Jiří Pařenica et al. · Journal of Critical Care · 2012 · 54 citations

Heart Failure, Acute Heart Failure—results, Cardiorenal Syndromes +10

Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

Sylvia Haas, Walter Ageno, Jeffrey I. Weitz et al. · Journal of Thrombosis and Haemostasis · 2019 · 41 citations · Full text

Acute Treatment, Thrombosis, Pulmonary Embolism +11